Applications are now open for AGA abstract awards
The application deadline is Thursday, Feb. 20, 2025.
New guideline provides practical guidance for therapy selection for moderate-to-severe ulcerative colitis
Using a rigorous process, we group 12 therapies by efficacy, suggesting early use of advanced therapies over a step-up approach after treatment failure.
Powerhouse women in GI support up-and-comers
Attendees received advice on leadership and work-life integration at the AGA Southeast Women in GI Regional Workshop.
Microbiome Minute: SLC26A6 loss & the microbiome
Dr. Phillip Tarr, chair of AGA’s microbiome center, provides a review on a recent Gastroenterology article.
Congrats to Dr. Abreu on her new IBD director position
Cedars-Sinai appointed AGA President Dr. Maria Abreu as the executive director of the F. Widjaja Inflammatory Bowel Disease Institute.
Best practices for using IBD endoscopic scoring systems
Experts provide tips for assessing mucosal healing in patients with IBD, including ulcerative colitis and Crohn’s disease.
GI payment cuts on the horizon for 2025
We will continue to urge Congress to address the unacceptable payment cuts proposed in the 2025 Medicare Physician Fee Schedule.
During NP Week, AGA launches NPPA Task Force
The NPPA Task Force will develop ideas for educational programs catered to the unique needs of nurse practitioners and physician assistants.
Are you up to date on biosimilar best practices? Take our GI Pop Quiz!
Think you’ve mastered the best practices for switching to a biosimilar? Now’s your chance to find out. Test your knowledge with our new interactive course — GI Pop Quiz! Biosimilars in IBD — and sharpen your skills in navigating the evolving landscape of biosimilars in clinical practice. This quick, engaging session challenges you to think […]
Save your spot in two Gastro Bites sessions in November
Join us on Nov. 8 and Nov. 19 for a recap of UEGW research and a discussion on AI.
